At Beacon Angel’s first meeting of 2023, members entertained funding proposals from the following:
- FluidIQ, developing a lung-safe, gas-powered respiratory resuscitator for use by EMTs and emergency doctors; and
- Echas, enabling an individual suffering from a possible heart attack or stroke to self-diagnose using his smartphone.
Members discussed the funding rounds by Series number, of:
- S 86B Lenoss Medical;
- S 106 Xeno;
- S 96B NF2 Therapeutics;
- S 104 Hilltop Biosciences;
- S 108 AOA Dx; and
- S 109 QSM Dx.